Adma Biologics reported $74.94M in Current Liabilities for its fiscal quarter ending in June of 2025.


Current Liabilities Change Date
Adma Biologics USD 74.94M 19.4M Jun/2025
Alnylam Pharmaceuticals USD 1.3B 225.22M Jun/2025
Dynavax Technologies USD 118.23M 49.85M Jun/2025
Takeda JPY 2.17T 336.94B Jun/2025